You are hereBiblio

Biblio


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
BIOTECHNOLOGY
Gene Therapy Oversight: Lessons for Nanobiotechnology, Wolf, Susan M., Gupta Rishi, and Kohlhepp Peter , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.659-684, (2009) Abstract

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, Paradise, Jordan, Wolf Susan M., Kuzma Jennifer, Kuzhabekova Aliya, Tisdale Alison W., Kokkoli Efrosini, and Ramachandran Gurumurthy , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.688-705, (2009) Abstract

Paradise, Jordan 1 Wolf, Susan M. 2 Kuzma, Jennifer 3 Kuzhabekova, Aliya 4 Tisdale, Alison W. 5 Kokkoli, Efrosini 6 Ramachandran, Gurumurthy 7; Affiliation: 1: Professor of Law at Seton Hall University School of Law. 2: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law, and Professor of Medicine at the University of Minnesota. 3: Associate Professor and area chair of Science, Technology and Environmental Policy at the Hubert Humphrey Institute of Public Affairs at the University of Minnesota. 4: Ph.D. candidate in Education Policy at the Hubert H. Humphrey Institute of Public Affairs at the University of Minnesota. 5: M.S. candidate in Chemical Engineering and Materials Science at the University of Minnesota. 6: Assistant Professor in Chemical Engineering and Materials Science at the University of Minnesota. 7: Professor in the University of Minnesota's School of Public Health.; Source Info: Winter2009, Vol. 37 Issue 4, p688; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: LEGISLATIVE oversight -- United States; Subject Term: PRODUCT safety; Subject Term: QUALITATIVE research; Subject Term: QUANTITATIVE research; Subject Term: TECHNOLOGICAL innovations; Subject Term: EVALUATION; Number of Pages: 18p; Illustrations: 3 Diagrams, 4 Charts; Document Type: Article

EVALUATION
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, Paradise, Jordan, Wolf Susan M., Kuzma Jennifer, Kuzhabekova Aliya, Tisdale Alison W., Kokkoli Efrosini, and Ramachandran Gurumurthy , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.688-705, (2009) Abstract

Paradise, Jordan 1 Wolf, Susan M. 2 Kuzma, Jennifer 3 Kuzhabekova, Aliya 4 Tisdale, Alison W. 5 Kokkoli, Efrosini 6 Ramachandran, Gurumurthy 7; Affiliation: 1: Professor of Law at Seton Hall University School of Law. 2: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law, and Professor of Medicine at the University of Minnesota. 3: Associate Professor and area chair of Science, Technology and Environmental Policy at the Hubert Humphrey Institute of Public Affairs at the University of Minnesota. 4: Ph.D. candidate in Education Policy at the Hubert H. Humphrey Institute of Public Affairs at the University of Minnesota. 5: M.S. candidate in Chemical Engineering and Materials Science at the University of Minnesota. 6: Assistant Professor in Chemical Engineering and Materials Science at the University of Minnesota. 7: Professor in the University of Minnesota's School of Public Health.; Source Info: Winter2009, Vol. 37 Issue 4, p688; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: LEGISLATIVE oversight -- United States; Subject Term: PRODUCT safety; Subject Term: QUALITATIVE research; Subject Term: QUANTITATIVE research; Subject Term: TECHNOLOGICAL innovations; Subject Term: EVALUATION; Number of Pages: 18p; Illustrations: 3 Diagrams, 4 Charts; Document Type: Article

GENE therapy
Gene Therapy Oversight: Lessons for Nanobiotechnology, Wolf, Susan M., Gupta Rishi, and Kohlhepp Peter , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.659-684, (2009) Abstract

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

GENETIC transformation
Gene Therapy Oversight: Lessons for Nanobiotechnology, Wolf, Susan M., Gupta Rishi, and Kohlhepp Peter , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.659-684, (2009) Abstract

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

LEGISLATIVE oversight -- United States
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, Paradise, Jordan, Wolf Susan M., Kuzma Jennifer, Kuzhabekova Aliya, Tisdale Alison W., Kokkoli Efrosini, and Ramachandran Gurumurthy , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.688-705, (2009) Abstract

Paradise, Jordan 1 Wolf, Susan M. 2 Kuzma, Jennifer 3 Kuzhabekova, Aliya 4 Tisdale, Alison W. 5 Kokkoli, Efrosini 6 Ramachandran, Gurumurthy 7; Affiliation: 1: Professor of Law at Seton Hall University School of Law. 2: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law, and Professor of Medicine at the University of Minnesota. 3: Associate Professor and area chair of Science, Technology and Environmental Policy at the Hubert Humphrey Institute of Public Affairs at the University of Minnesota. 4: Ph.D. candidate in Education Policy at the Hubert H. Humphrey Institute of Public Affairs at the University of Minnesota. 5: M.S. candidate in Chemical Engineering and Materials Science at the University of Minnesota. 6: Assistant Professor in Chemical Engineering and Materials Science at the University of Minnesota. 7: Professor in the University of Minnesota's School of Public Health.; Source Info: Winter2009, Vol. 37 Issue 4, p688; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: LEGISLATIVE oversight -- United States; Subject Term: PRODUCT safety; Subject Term: QUALITATIVE research; Subject Term: QUANTITATIVE research; Subject Term: TECHNOLOGICAL innovations; Subject Term: EVALUATION; Number of Pages: 18p; Illustrations: 3 Diagrams, 4 Charts; Document Type: Article

MEDICINE -- Research
Gene Therapy Oversight: Lessons for Nanobiotechnology, Wolf, Susan M., Gupta Rishi, and Kohlhepp Peter , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.659-684, (2009) Abstract

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

NANOTECHNOLOGY
Gene Therapy Oversight: Lessons for Nanobiotechnology, Wolf, Susan M., Gupta Rishi, and Kohlhepp Peter , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.659-684, (2009) Abstract

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, Paradise, Jordan, Wolf Susan M., Kuzma Jennifer, Kuzhabekova Aliya, Tisdale Alison W., Kokkoli Efrosini, and Ramachandran Gurumurthy , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.688-705, (2009) Abstract

Paradise, Jordan 1 Wolf, Susan M. 2 Kuzma, Jennifer 3 Kuzhabekova, Aliya 4 Tisdale, Alison W. 5 Kokkoli, Efrosini 6 Ramachandran, Gurumurthy 7; Affiliation: 1: Professor of Law at Seton Hall University School of Law. 2: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law, and Professor of Medicine at the University of Minnesota. 3: Associate Professor and area chair of Science, Technology and Environmental Policy at the Hubert Humphrey Institute of Public Affairs at the University of Minnesota. 4: Ph.D. candidate in Education Policy at the Hubert H. Humphrey Institute of Public Affairs at the University of Minnesota. 5: M.S. candidate in Chemical Engineering and Materials Science at the University of Minnesota. 6: Assistant Professor in Chemical Engineering and Materials Science at the University of Minnesota. 7: Professor in the University of Minnesota's School of Public Health.; Source Info: Winter2009, Vol. 37 Issue 4, p688; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: LEGISLATIVE oversight -- United States; Subject Term: PRODUCT safety; Subject Term: QUALITATIVE research; Subject Term: QUANTITATIVE research; Subject Term: TECHNOLOGICAL innovations; Subject Term: EVALUATION; Number of Pages: 18p; Illustrations: 3 Diagrams, 4 Charts; Document Type: Article

PRODUCT safety
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, Paradise, Jordan, Wolf Susan M., Kuzma Jennifer, Kuzhabekova Aliya, Tisdale Alison W., Kokkoli Efrosini, and Ramachandran Gurumurthy , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.688-705, (2009) Abstract

Paradise, Jordan 1 Wolf, Susan M. 2 Kuzma, Jennifer 3 Kuzhabekova, Aliya 4 Tisdale, Alison W. 5 Kokkoli, Efrosini 6 Ramachandran, Gurumurthy 7; Affiliation: 1: Professor of Law at Seton Hall University School of Law. 2: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law, and Professor of Medicine at the University of Minnesota. 3: Associate Professor and area chair of Science, Technology and Environmental Policy at the Hubert Humphrey Institute of Public Affairs at the University of Minnesota. 4: Ph.D. candidate in Education Policy at the Hubert H. Humphrey Institute of Public Affairs at the University of Minnesota. 5: M.S. candidate in Chemical Engineering and Materials Science at the University of Minnesota. 6: Assistant Professor in Chemical Engineering and Materials Science at the University of Minnesota. 7: Professor in the University of Minnesota's School of Public Health.; Source Info: Winter2009, Vol. 37 Issue 4, p688; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: LEGISLATIVE oversight -- United States; Subject Term: PRODUCT safety; Subject Term: QUALITATIVE research; Subject Term: QUANTITATIVE research; Subject Term: TECHNOLOGICAL innovations; Subject Term: EVALUATION; Number of Pages: 18p; Illustrations: 3 Diagrams, 4 Charts; Document Type: Article

QUALITATIVE research
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, Paradise, Jordan, Wolf Susan M., Kuzma Jennifer, Kuzhabekova Aliya, Tisdale Alison W., Kokkoli Efrosini, and Ramachandran Gurumurthy , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.688-705, (2009) Abstract

Paradise, Jordan 1 Wolf, Susan M. 2 Kuzma, Jennifer 3 Kuzhabekova, Aliya 4 Tisdale, Alison W. 5 Kokkoli, Efrosini 6 Ramachandran, Gurumurthy 7; Affiliation: 1: Professor of Law at Seton Hall University School of Law. 2: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law, and Professor of Medicine at the University of Minnesota. 3: Associate Professor and area chair of Science, Technology and Environmental Policy at the Hubert Humphrey Institute of Public Affairs at the University of Minnesota. 4: Ph.D. candidate in Education Policy at the Hubert H. Humphrey Institute of Public Affairs at the University of Minnesota. 5: M.S. candidate in Chemical Engineering and Materials Science at the University of Minnesota. 6: Assistant Professor in Chemical Engineering and Materials Science at the University of Minnesota. 7: Professor in the University of Minnesota's School of Public Health.; Source Info: Winter2009, Vol. 37 Issue 4, p688; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: LEGISLATIVE oversight -- United States; Subject Term: PRODUCT safety; Subject Term: QUALITATIVE research; Subject Term: QUANTITATIVE research; Subject Term: TECHNOLOGICAL innovations; Subject Term: EVALUATION; Number of Pages: 18p; Illustrations: 3 Diagrams, 4 Charts; Document Type: Article

QUANTITATIVE research
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, Paradise, Jordan, Wolf Susan M., Kuzma Jennifer, Kuzhabekova Aliya, Tisdale Alison W., Kokkoli Efrosini, and Ramachandran Gurumurthy , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.688-705, (2009) Abstract

Paradise, Jordan 1 Wolf, Susan M. 2 Kuzma, Jennifer 3 Kuzhabekova, Aliya 4 Tisdale, Alison W. 5 Kokkoli, Efrosini 6 Ramachandran, Gurumurthy 7; Affiliation: 1: Professor of Law at Seton Hall University School of Law. 2: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law, and Professor of Medicine at the University of Minnesota. 3: Associate Professor and area chair of Science, Technology and Environmental Policy at the Hubert Humphrey Institute of Public Affairs at the University of Minnesota. 4: Ph.D. candidate in Education Policy at the Hubert H. Humphrey Institute of Public Affairs at the University of Minnesota. 5: M.S. candidate in Chemical Engineering and Materials Science at the University of Minnesota. 6: Assistant Professor in Chemical Engineering and Materials Science at the University of Minnesota. 7: Professor in the University of Minnesota's School of Public Health.; Source Info: Winter2009, Vol. 37 Issue 4, p688; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: LEGISLATIVE oversight -- United States; Subject Term: PRODUCT safety; Subject Term: QUALITATIVE research; Subject Term: QUANTITATIVE research; Subject Term: TECHNOLOGICAL innovations; Subject Term: EVALUATION; Number of Pages: 18p; Illustrations: 3 Diagrams, 4 Charts; Document Type: Article

RESEARCH
Gene Therapy Oversight: Lessons for Nanobiotechnology, Wolf, Susan M., Gupta Rishi, and Kohlhepp Peter , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.659-684, (2009) Abstract

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

TECHNOLOGICAL innovations
Gene Therapy Oversight: Lessons for Nanobiotechnology, Wolf, Susan M., Gupta Rishi, and Kohlhepp Peter , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.659-684, (2009) Abstract

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, Paradise, Jordan, Wolf Susan M., Kuzma Jennifer, Kuzhabekova Aliya, Tisdale Alison W., Kokkoli Efrosini, and Ramachandran Gurumurthy , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.688-705, (2009) Abstract

Paradise, Jordan 1 Wolf, Susan M. 2 Kuzma, Jennifer 3 Kuzhabekova, Aliya 4 Tisdale, Alison W. 5 Kokkoli, Efrosini 6 Ramachandran, Gurumurthy 7; Affiliation: 1: Professor of Law at Seton Hall University School of Law. 2: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law, and Professor of Medicine at the University of Minnesota. 3: Associate Professor and area chair of Science, Technology and Environmental Policy at the Hubert Humphrey Institute of Public Affairs at the University of Minnesota. 4: Ph.D. candidate in Education Policy at the Hubert H. Humphrey Institute of Public Affairs at the University of Minnesota. 5: M.S. candidate in Chemical Engineering and Materials Science at the University of Minnesota. 6: Assistant Professor in Chemical Engineering and Materials Science at the University of Minnesota. 7: Professor in the University of Minnesota's School of Public Health.; Source Info: Winter2009, Vol. 37 Issue 4, p688; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: LEGISLATIVE oversight -- United States; Subject Term: PRODUCT safety; Subject Term: QUALITATIVE research; Subject Term: QUANTITATIVE research; Subject Term: TECHNOLOGICAL innovations; Subject Term: EVALUATION; Number of Pages: 18p; Illustrations: 3 Diagrams, 4 Charts; Document Type: Article